Heart Failure Treatment and Management
This cluster of papers focuses on the diagnosis, treatment, and management of heart failure, including guidelines, epidemiology, B-type natriuretic peptide testing, cardiovascular disease burden, hospital readmission rates, risk prediction models, and the impact of renal function on outcomes.
Papers listed on taxonomy pages are the top few works per node from the OpenAlex snapshot. That list is not exhaustive and is not an endorsement. The topic map and the journal registry remain separate: there is still no authoritative topic-to-venue or topic-to-organization edge. Search is a lexical lookup, not a claim that a venue publishes a topic.
Most cited
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Most recent
- Impact of Omitting Observation-Status Data on Hospital Readmission Metric for Pediatric Care
- Get With The Guidelines–Heart Failure Hospital Participation and Its Association With Guideline-Directed Medical Therapy and Outcomes
- Telehealth in Heart Failure Management: A Scoping Review
- Tos inducida por inhibidores de la enzima convertidora de angiotensina frente a bloqueadores de los receptores de angiotensina II en la hipertensión arterial: Incidencia, mecanismos fisiopatológicos y repercusión en la adherencia terapéutica
- Concordance Between E/e’ Ratio and N-Terminal Pro-B-type Natriuretic Peptide Levels for Predicting Post-Discharge Heart Failure Events Within Ninety Days After Acute Coronary Syndrome
- Clinical and Metabolic Factors as Predictors of Thirty-Day Readmission in Patients With Acute Decompensated Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus